Agoracom Blog Home

Archive for the ‘Featured’ Category

FansUnite Entertainment $FANS.ca $FUNFF and GameCo to Create the First #Esports Sportsbook in the United States with Sky Ute Casino in Colorado $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

Posted by AGORACOM-JC at 11:01 AM on Wednesday, December 16th, 2020
  • FansUnite will gain first-mover advantage into the U.S. esports betting market through long term partnership with GameCo
  • Announced its partner, GameCo LLC (“GameCo”), a Las Vegas based pioneer in Video Game Gambling™, has entered into a partnership with US Bookmaking and Sky Ute Casino
  • To establish the first dedicated esports sportsbook in the United States.
  • Wholly owned subsidiary Askott Entertainment will supply its iGaming platform, Chameleon, as part of a fully integrated esports betting solution.

Vancouver, British Columbia–(December 16, 2020) – FansUnite Entertainment Inc (CSE: FANS) (OTCQB: FUNFF) (“FansUnite” or the “Company”), a technology company providing leading online gaming solutions, is pleased to announce its partner, GameCo LLC (“GameCo”), a Las Vegas based pioneer in Video Game Gambling™, has entered into a partnership with US Bookmaking and Sky Ute Casino to establish the first dedicated esports sportsbook in the United States. Wholly owned subsidiary Askott Entertainment will supply its iGaming platform, Chameleon, as part of a fully integrated esports betting solution.

Through GameCo’s partnership with Sky Ute Casino and US Bookmaking, FansUnite will be the first iGaming solutions provider to receive significant exposure in the U.S. esports betting market.

As previously announced on September 2nd, 2020, FansUnite entered into a partnership with GameCo to establish a fully integrated turnkey esports betting solution for online casinos and sportsbooks in the United States. Under the agreement with GameCo and Sky Ute Casino, Askott Entertainment’s Chameleon iGaming Platform will form the basis of GameCo’s esports betting offering alongside GRID’s data platform and 10Star’s odds feed and risk management services, resulting in an esports sportsbook with extensive and broad-ranging services that are geared towards the younger demographic of online gamblers.

“We are delighted to be part of the first-ever real money esports sportsbook in the U.S. as it represents a major milestone for FansUnite and the entire betting community globally,” said Scott Burton, CEO of FansUnite Entertainment. “Entering the U.S. market has always been part of our growth roadmap and partnering with GameCo in September represented a channel for us to introduce our leading B2B esports betting solution to a sizable and growing market. This latest customer win has exceeded our own expectations and validates our technology, strategy, and legitimacy of our organization. With our first casino customer now in hand, we are eager to continue our collaboration with GameCo, GRID, and 10 Star to establish a larger presence in the U.S. market.”

Blaine Graboyes, Co-Founder and CEO of GameCo added, “This marks a new era for GameCo as we will be the frontrunners in capturing revenue from an untouched segment in the U.S. online casino market. We require the most innovative technology that will provide a strong backbone for our betting systems and we are pleased that FansUnite is able to fulfill that need with the Chameleon iGaming solutions.”

About FansUnite Entertainment Inc.

FansUnite is a global sports and entertainment company, focusing on technology related to regulated and lawful online gaming and other related products. FansUnite has produced a one of a kind complete iGaming platform, with a sports and esports focus geared for the next generation of online bettors and casino players. The platform includes products for pre-match betting, in-play betting, daily fantasy, content and a certified RNG to produce casino style chance games. The platform operates multiple B2C brands and B2B software for the online gambling industry. FansUnite also looks to acquire technology platforms and assets with high-growth potential in new or developing markets.

About GameCo

GameCo LLC creates revolutionary gaming products and experiences that drive growth and deliver a new, different, and younger player for digital and retail casinos. The inventor of the world’s first skill-based Video Game Gambling Machine (VGM™), GameCo’s omnichannel land-based and online platform combines the fun and interactivity of video games with the thrill and anticipation of gambling. Through its iGameCo brand, GameCo develops unique video game gambling titles for digital casinos and provides the first turnkey, outsourced, full-service esports betting solution built specifically for the regulated US market. GameCo’s Video Game Gambling™ platform and patent-pending GamersEdge™ technology enables game developers and publishers to distribute and monetize video games into regulated gaming markets. GameCo offers single player and esports-style multiplayer games with a wide portfolio of sports, casual, and arcade titles that also feature brand licenses from major studios and celebrities such as Steve Aoki from DJ Kid Millionaire LTD., “SOULCALIBUR™II” with BANDAI NAMCO Amusement Inc., and Star Trek™ with CBS Consumer Products, Inc.

GameCo LLC is privately held and headquartered in Las Vegas and currently licensed to operate in more than twenty gaming jurisdictions, including Nevada. For the latest GameCo news, please visit https://gameco.com/product or follow the company on Twitter at twitter.com/GameCoLLC.

For further information, please contact:

Prit Singh Investor Relations at FansUnite
[email protected]
(905) 510-7636

Scott Burton Chief Executive Officer of FansUnite
[email protected]

Darius Eghdami President of FansUnite
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

FORWARD-LOOKING STATEMENTS: Certain information contained herein may constitute “forward-‎‎looking information” under Canadian securities legislation. Generally, forward-looking information can be ‎‎identified by the use of forward-looking terminology such as “believes,” “belief,” “expects,” “intends,” ‎‎‎”anticipates,” “potential,” “should,” “may,” “will,” “plans,” “continue” or similar expressions to be uncertain ‎‎and forward-looking. Forward-looking statements may include, without limitation, statements relating to ‎‎future outlook and anticipated events such as: the extent and range of FansUnite’s iGaming platform; target demographics of FansUnite; growth of the U.S. ‎market; expansion of FansUnite into the U.S. market; the position of FansUnite and GameCo as ‎frontrunners in the US online casino market; FansUnite’s ability to fulfill technology needs with its ‎platform; GameCo’s ability to enable the distribution and monetization of video games into the licensed ‎gaming market and to attract new customers;‎ business development ‎plans of FansUnite and GameCo; the Company’s unique portfolio of assets; and discussion of future plans, projections, ‎objectives, estimates ‎and forecasts and the timing related thereto. Forward-looking statements are based ‎on the Company’s ‎estimates and are subject to known and unknown risks, uncertainties and other factors ‎that may cause the ‎actual results, level of activity, performance or achievements of FansUnite to be ‎materially different from ‎those expressed or implied by such forward-looking statements or forward-looking ‎information. Additional ‎information regarding the risks and uncertainties relating to the Company’s business ‎are contained under ‎the heading “Risk Factors” in the Company’s Non-Offering Prospectus dated March 27, ‎‎2020 filed on its ‎issuer profile on SEDAR at www.sedar.com and risks related to global pandemics, ‎including the novel ‎coronavirus (COVID-19) global health pandemic, and the spread of other viruses or ‎pathogens and influence ‎of macroeconomic developments. Accordingly, readers should not place undue ‎reliance on forward-looking ‎statements and forward-looking information. The forward-looking statements in ‎this news release are made ‎as of the date of this release. FansUnite disclaims and does not undertake to ‎update or revise any forward-‎looking statements or forward-looking information, whether as a result of new ‎information, future events or ‎otherwise, except as required by applicable securities laws.‎

PyroGenesis $PYR.ca Signs Additional $1.1MM Contract with US Tunneling Company $RTN $NOC $UTX $DDD.ca $HPQ.ca

Posted by AGORACOM-JC at 8:45 AM on Wednesday, December 16th, 2020
  • Further to its press releases dated April 1 st and 21 st , 2020, it has signed an additional contract (the “Contract”) with a US based tunneling client (the “Client”) for approx. $1.1MM.
  • The total value of all contracts, including the one announced today, entered into with the Client is in excess of $3.6MM.
  • The Company has received $1.3MM to date under these contracts.
  • The Client’s name will remain confidential for competitive reasons.

MONTREAL, Dec. 16, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQB: PYRNF) (FRA: 8PY), (the “Company”, the “Corporation” or “PyroGenesis”) a Company that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to announce today that, further to its press releases dated April 1 st and 21 st , 2020, it has signed an additional contract (the “Contract”) with a US based tunneling client (the “Client”) for approx. $1.1MM. The total value of all contracts, including the one announced today, entered into with the Client is in excess of $3.6MM. The Company has received $1.3MM to date under these contracts. The Client’s name will remain confidential for competitive reasons.

Based on these contracts, PyroGenesis will be designing, manufacturing, testing and supplying the Client with a plasma torch tailored specifically for tunneling (the “TT1 Torch”). The TT1 Torch is expected to be delivered in the second half of 2021, at which time it will then be tested. The Client is committed to purchase exclusively from PyroGenesis, and the Company is committed to exclusively supply the Client with plasma torches and auxiliary equipment for tunneling applications.

PyroGenesis’ high-powered plasma torch will be used to replace traditional tunneling methods. An important benefit in using plasma-based tools versus traditional methods is its potential to drill through all geologies with greater flexibility in size diameter, while at the same time being more economical, efficient and environmentally friendly.

“This is the second announcement PyroGenesis has made in as many months which highlight advances in our plasma torch offerings,” said Mr. P Peter Pascali, CEO and Chair of PyroGenesis. “As you can see, not only are our torch offerings steadily moving forward, but are doing so in totally independent applications. This bodes well for the future and once again, underscores both the interest in, and versatility of, our torch offerings which at the same time are being recognized as effective environmental solutions.”

About PyroGenesis Canada Inc

PyroGenesis Canada Inc., a high-tech company, is a leader in the design, development, manufacture and commercialization of advanced plasma processes and products. The Company provides its engineering and manufacturing expertise and its turnkey process equipment packages to customers in the defense, metallurgical, mining, advanced materials (including 3D printing), and environmental industries. With a team of experienced engineers, scientists and technicians working out of its Montreal office and its 3,800 m 2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The Company’s core competencies allow PyroGenesis to provide innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. PyroGenesis’ operations are ISO 9001:2015 and AS9100D certified. For more information, please visit www.pyrogenesis.com .

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com . Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the Toronto Stock Exchange, its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:
Rodayna Kafal, Vice President, IR/Comms. and Strategic BD
Phone: (514) 937-0002, E-mail: [email protected]

RELATED LINK: http://www.pyrogenesis.com/

Datametrex AI $DM.ca $DTMXF Announces Release of Nexalogy “SMART” Technology $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 7:28 AM on Wednesday, December 16th, 2020
  • Announced the release of Nexalogy SMART – Social Media Automated Reporting Technology
  • As previously announced, Nexalogy’s SMART is an advanced proprietary AI technology
  • SMART minimizes human involvement in data analysis and reporting.
  • It significantly decreases the time required for integration and interpretation of large data sets and report production
  • Now fully available

Toronto, Ontario–(December 16, 2020) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce the release of Nexalogy SMART – Social Media Automated Reporting Technology.

As previously announced, Nexalogy’s SMART is an advanced proprietary AI technology. SMART minimizes human involvement in data analysis and reporting. It significantly decreases the time required for integration and interpretation of large data sets and report production. It is now fully available.

SMART takes NexaIntelligence to the next level with AI-powered automated reporting technology. It quickly generates reports with all of NexaIntelligence’s visualizations, augmenting the reporting capacity of analysts. Human resources are a scarce commodity. SMART integrates larger sets of data into smaller, more manageable reports, thus significantly reducing the number of resource hours required to identify insights.

Our AI pre-reads text, selects verbatims, and summarizes themes quickly, reliably, and with precision. The AI technology creates powerful reports based on our algorithms and automatically selects the most important original posts to include, in minutes rather than hours. Analysts can specify filters on the data to get automatic reports on subsets of the data focusing on specific times, entities, social media users, or topics. This means social media trends can be understood faster and with less difficulty, keeping companies ahead of the curve.

SMART’s scheduling functionality allows companies to structure reporting to match regular schedules as needed or in response to triggering events in the data itself. AI-written reports are emailed to analysts inconvenient and easy to read file formats, such as MSWORD or PDF. Raw JSON outputs from Nexalogy’s API are also available for use in white labelled products.

AI reporting on social media and other forms of unstructured text is increasingly important and relevant in the information landscape. The need for strategic reporting of data from these platforms in both the public and private sectors is growing at a rapid pace. The ability to analyze and monetize social media discussions, as well as unstructured text from owned sources, are key strengths of SMART. Breaking through information bottlenecks and resource limitations, SMART can take big data discovery and exploration to a new level of actionable insights.

“Our AI helps you unlock the power of discovery, converting unknown unknowns into known knowns, activating the hidden potential currently lost in big data. With social media and unstructured text being a key facet of how businesses and consumers connect during the pandemic, we feel SMART is uniquely positioned to assist clients in unlocking potential in current verticals and exploring the potential of new verticals; for security, we help you discover unknown problems so you can squash them before they become big problems. For growth, we help you discover and unlock hidden potential,” said Marshall Gunter, CEO of Datametrex AI Limited.

To see more and download example reports, click here: https://nexalogy.com/product/

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

###

Kontrol $KNR $KNR.ca $KNR.c $KNRLF Completes Debenture Exchange and Announces Intention to Begin Process of Uplisting to Major North American Stock Exchanges $SNE $MSFT $HON $GOOGL $QCOM

Posted by AGORACOM-JC at 7:22 AM on Wednesday, December 16th, 2020
kontrol-logo
  • Company’s board of directors has authorized management to review the process to graduate the Company from the CSE to the TSX
  • If the Company is successful in uplisting to the TSX, Kontrol intends to, as soon as practical, begin the process of filing a Form F-1 Registration Statement with the Securities and Exchange Commission of the United States, which will enable Kontrol to apply to be listed on the NASDAQ

TORONTO, ON / December 16, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“), a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce that it has completed its previously announced debenture exchange (see press release dated June 9, 2020 and November 2, 2020) by private placement. The 2020 Debenture holders exchanged a total of $3,650,000 for 2022 Debentures and new proceeds of $871,000 were raised. The remaining 2020 Debenture balance of $2,061,000 was redeemed in cash by the Company. Each unit is comprised of one $1,000 8% unsecured debenture (and non-convertible) of the Company maturing on October 31, 2022 and 10 common shares.

Paul Ghezzi, CEO of Kontrol, commented:

“With the exchange of the 2020 Debentures we have improved the balance sheet and the Company’s net equity position. As we continue to execute on our business plan, we believe this is an opportune time to begin the graduation process to the senior North American exchanges for an uplisting in 2021.”

Name Change

Further to the passing of a resolution of shareholders at its most recent general and special meeting of shareholders, the Company intends to proceed with a corporate name change to “Kontrol Technologies Corp.”, which is anticipated to be completed prior to December 31, 2020.

Uplisting to TSX, NASDAQ

The Company’s board of directors has authorized management to review the process to graduate the Company from the CSE to the TSX. If the Company is successful in uplisting to the TSX, Kontrol intends to, as soon as practical, begin the process of filing a Form F-1 Registration Statement with the Securities and Exchange Commission of the United States (the “SEC“), which will enable Kontrol to apply to be listed on the NASDAQ.

Completion of any uplisting is subject to meeting certain conditions, as well as the approval of the TSX. There is no assurance that the TSX will approve the listing application or that Kontrol will complete the uplisting as contemplated. There is no assurance that either the SEC or NASDAQ will approve the Company’s respective applications or that Kontrol will complete the listing to the NASDAQ as proposed.

About Kontrol Energy

Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com

For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE: Kontrol Energy Corp.

AGORACOM Welcomes Valeo Pharma $VPH.ca $VPHIF With 7 Products To Be Launched In 2021 / 2022 ($45M. Estimated Peak Sales / Year) $HLS.ca $MDP.ca $GUD.ca $RX.ca

Posted by AGORACOM-JC at 3:31 PM on Tuesday, December 15th, 2020

(VPH: CSE) (VPHIF: OTCQB) (VP2: FSE)

www.valeopharma.com

Why Valeo Pharma?

  • Commercial stage revenue generating Canadian pharmaceutical company
  • Approaching EBITDA positive in coming months
  • 9 products currently marketed ($40M. estimated peak sales / year)
  • 7 additional products in pipeline ($45M. estimated peak sales / year)
  • In-license business model, no development or clinical risk
  • $1.5M in quarterly revenue ending July 31, 2020
  • $5.26M in revenue for 9 months ending July 31, 2020

What Exactly Does Valeo Pharma Do?

  • Acquires Canadian rights to commercial stage, innovative and proprietary drugs
  • Commercializes innovative prescription products in Canada
  • Focused on Neurodegenerative Diseases,  Oncology and Hospital Specialty Products
  • Internally manages portfolio through all stages of commercialization

Commercial Portfolio

VPH-Commercial-Portfolio

Here’s just a few products already approved:

BRAND: REDESCA® (BIOSIMILAR)

Launch: Q1-2021

Status: Approved by Health Canada December 2020

Indication: Injectable blood thinner

Market size:  $200M

Peak sales estimate $30 – $40M, sales margin 55 – 60% https://www.youtube.com/embed/XNn29Cx2ToY

BRAND: HESPERCOTM

Launch: Launched in Q4 -2020

Status: Approved by Health Canada

What is it: Anti-Oxidant – Immune system support

How’s it sold: Retail, Online (www.hesperco.com, www.amazon.ca)

Market Size: $500M

hesperco

BRAND: ONSTRYV®

Launch: Q3 2019

Status: Received positive recommendation for public reimbursement in Quebec

Use: Parkinson’s disease, 1st treatment launched in Canada since 2006

Patient base: 100,000 in Canada 2nd chronic neurodegenerative disorder after Alzheimer

Market Size: $20M

%Peak sales estimate $8M, sales margin 65-70 %

Pipeline

Pipeline

The Valeo Model

Company Forecast

  • All portfolio & pipeline products to be on the market by end 2022
  • Solid pipeline composed of “licensed” products
  • Peak Sales reached 2-4 years after market launch
  • From 1 product on the market to 12 in 4 years and more to come
  • Forecast excludes any new product licensing

Hub On AGORACOM / Corporate Profile

AGORACOM Small Cap 60: $KABN.ca A #Fintech Platform Focused On Verifying, Managing & Monetizing Online Identity $MOS.ca $MOGO.ca $CTZ.ca

Posted by AGORACOM-JC at 1:09 PM on Tuesday, December 15th, 2020
kabn-square-new

GENERALLY KABN Turns The Problem Of Data Privacy Into A Profit For Individuals, While Providing Big Businesses With New & Compliant Business Models.

SPECIFICALLY KABN Specializes In

  • Continuous Online Identity Verification
  • Personal Identity Management
  • Personal Data Monetization.

NEW DIGITAL PRIVACY LAWS OVER THE LAST 2 YEARS ARE DRIVING CUSTOMERS TO KABN FOR THE FOLLOWING REASONS:

  • Your Online Privacy & Data Protection Is More Important Now Than Ever
  • Facebook Data Privacy Scandal Lead To The Implementation of GDPR (General Data Protection Regulation
  • GDPR Is Essentially EU Law On Digital Privacy That Strongly Regulates The Transfer Of Personal Data.
  • The Primary Purpose Of GDPR Is To Give Individuals Control Over Their Personal Data By Regulating All International Businesses That Handle Our Data
  • GDPR Became Effective May 25, 2018
  •  GDPR Was Followed By The California Consumer Privacy Act of 2018 (CCPA)
  • The CCPA Became Effective January 1, 2020.
  • Both Will Have A Significant Impact On The Way These Industries Collect and Capitalize On Personal Data
    • Social Media               (Facebook, Twitter, etc.)
    • E-commerce                (Amazon, Ali Baba, etc.)
    • Digital Payments         (PayPal, AliPay, etc.)
    • Cloud Computing       (AWS, Azure, etc.)
    • iGaming / Gambling    (Bet365, Tencent, Epic Games, etc.)

Hub On AGORACOM / Corporate Profile

Datametrex $DM.ca $DTMXF Awarded Two Contracts with Insurance Provider and Airport Authority $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 7:51 AM on Tuesday, December 15th, 2020
  • Announced that it has been awarded two AI related contracts totalling $150,000 on the initial pilot contracts.
  • The first contract is for tech support for Incheon International Airport Corporation, a major airport in the Republic of Korea.
  • Company was also awarded a contract with ABL Life Insurance Co., Ltd. for job automation scheduling.
  • The Company commenced the work, and is already in negotiation to expand the scope of work and contract.

Toronto, Ontario–(December 15, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that it has been awarded two AI related contracts totalling $150,000 on the initial pilot contracts.

The first contract is for tech support for Incheon International Airport Corporation (“IIAC”), a major airport in the Republic of Korea.

Under the terms of the contract, Datametrex will provide AI for job automation scheduling using AI technologies in partnership with third party software from Sees solutions for Workload Automation-As-A-Service (“WAAAS”). The batch job scheduler will help automate the workflow with all batch jobs that are software managed and approve the results of the execution by WAAAS. Integrated batch job scheduler systems are linked to the existing legacy system and each target system is configured to execute batch jobs. Once operational, the system will feature integrated batch job management, flexible approval system, efficient calendar management, secure security, optimal performance, and agent add-in are features that manage file transfer functions.

The Company was also awarded a contract with ABL Life Insurance Co., Ltd. (“ABL”) for job automation scheduling. The Company commenced the work, and is already in negotiation to expand the scope of work and contract.

About Incheon International Airport Corporation

Seoul Airport, known officially as Incheon International Airport (IATA: ICN, ICAO: RKSI), and is the largest and the primary airport serving Seoul, the capital of South Korea. The airport employs over 40,000 people and include airport management staff, security personnel and system managers.

It is located west of Incheon city and 30 miles (48 km) west of Seoul. Incheon Airport consists of two passenger terminals, and has 111 boarding gates altogether, with 44 in Terminal 1, 30 in Concourse A (connected to Terminal 1), and 37 in Terminal 2. It has been rated as the one of the world’s cleanest airports and highly rated international transit airports by Skytrax. In 2019, the airport served a total of 70,857,908 passengers and ranked 8th in international passengers and 3rd in international cargo. Additional information on Incheon is available at www.airport.kr/

About ABL Life Insurance Co., Ltd

Founded in 1954, ABL Life provides insurance products and financial services to 1.13 million customers based on a nationwide sales network. ABL Life Insurance is striving to become “a reliable global life insurance company that provides ‘better life’ through advanced products and smart services.” Additional information on ABL is available at www.abllife.co.kr/

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Certain statements including in this news release contain “forward-looking information” or constitute “forward-looking statements” within the meaning of applicable securities laws. Such forward-looking statements or information are provided for the purpose of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy, including the dollar amount of revenue anticipated under the Agreement.

Forward-looking statements or information are based on current expectations, estimates and projections that involve several risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company and described in the forward-looking statements or information. These risks and uncertainties may cause actual results to differ materially from the forward-looking statements or information.

Readers are cautioned that the foregoing list is not exhaustive of all possible risks and uncertainties. Readers are also cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

###

$KABN.ca Liquid Avatar Partners with #Fintech Innovator #XTM to enable Hospitality, Personal Care, and other Industry Sectors to Verify COVID-19 Vaccination Verifiable Credentials $MOS.ca $MOGO.ca $CTZ.ca

Posted by AGORACOM-JC at 7:38 AM on Tuesday, December 15th, 2020
kabn-square-new
  • Announced that fintech innovator, XTM Inc. (CSE:PAID) (“XTM”) has joined its Verifiable Identity Healthcare Credential consortium to support the issuance, management and verification of COVID-19 digital diagnostic testing and vaccination verification for the hospitality, personal care and other business sectors that it services.
  • XTM joins consortium partners, Trust over IP Foundation, Lumedic, Loop Insights (TSXV:MTRX), The Campus Agency and TripXpertz.

TORONTO, ON / December 15, 2020 / KABN Systems NA Holdings Corp. (CSE:KABN) (the “Company” or “KABN North America”), a Canadian fintech company that specializes in continuous online identity verification, management and monetization in Canada and the US, through its biometrically and identity verified Self Sovereign Identity platform, Liquid Avatar (www.liquidavatar.com), today announces that fintech innovator, XTM Inc. (CSE:PAID) (“XTM”) has joined its Verifiable Identity Healthcare Credential consortium to support the issuance, management and verification of COVID-19 digital diagnostic testing and vaccination verification for the hospitality, personal care and other business sectors that it services. XTM joins consortium partners, Trust over IP Foundation, Lumedic, Loop Insights (TSXV:MTRX), The Campus Agency and TripXpertz.

XTM enables North American industry leaders in the hospitality, personal care and sports and entertainment sectors to power cashless payments to employees, including 7 of the 10 largest restaurant chains; 5 of the largest pizza delivery chains including Dominos and Boston Pizza; the largest personal care salon chain; and the largest Canadian sports and entertainment group.

“We’re excited to join KABN, Liquid Avatar and the other consortium partners to bring our expertise in reaching and supporting large organizations and their employees in the hospitality, personal care, food services and entertainment sector that have been adversely affected by the pandemic,” said Marilyn Schaffer, CEO of XTM. “Our goal is to help our industry partners, in any way possible, to support their current, limited activities, and to help create and support innovative solutions, like the Verifiable Identity Healthcare Credential initiative, so that restaurants, delivery services, salons and other personal care facilities and venues can safely and effectively expand operations to the public.”

The consortium has developed an integrated solution ecosystem that enables healthcare issuers, individuals and verifiers to have a digital COVID-19 verifiable identity healthcare credential that is secure, user managed and controlled to ensure privacy, transportability and ease of use. This solution supports the foundation for the acceptance of digital Healthcare Passports and allow qualified Health Professionals with the ability to issue a Verifiable Credential that enables venues and other facilities to verify both the issued credential and the known user in real-time to grant access and / or services.

The ecosystem is built on a Trust over IP (TOIP) open standards framework, and the World Wide Web Consortium’s (W3C) specifications for decentralized identifiers for credential management with the ability to issue, manage and verify interoperable COVID-19 vaccination and other verifiable credentials across a host of user managed and controlled digital wallets and applications.

Verifiable identity and access credentials can be used for multiple use cases such as Education, Workplaces, Tradeshows, Healthcare, Sporting Events, Concerts, Entertainment, Travel, Places of Worship, Senior Living, and other facilities, venues and locations and opens the door to further opportunities for commercial and consumer opportunities.

Powering and supporting the entire user experience, Liquid Avatar’s Self Sovereign Identity (SSI) platform, which includes user biometric validation and a bank-grade verified identity credential, is available to consumers at no cost. Liquid Avatar enables users to verify and manage their identity and access credentials in a cloud-based, biometrically secure application. Users have complete control over their digital assets (like wallets, passwords and more), identity, and data through easy-to-use avatars that can be shared, on a permission-basis with others.

The COVID-19 Verifiable Healthcare Credential combines healthcare data with the user’s biometrically verified identity credential. When a request is made by a Verifier, the User has a choice of which attributes are shared, creating a private verification transaction between themselves and a verifier. While much of the technology and services are already in place, the launch of the healthcare credential pilot is expected to take place in the first quarter of 2021 to coincide with the expected release of the COVID-19 widespread vaccination program. This solution will not only be able to verify identity credentials for the Covid-19 vaccines, diagnostic and antibody testing, but will also be able to support a wide range of immunizations and healthcare records.

“Liquid Avatar and the consortium partners are working together to create open-source solutions that can help empower users to return to public life and the things they once did freely, pre-COVID-19, with ease and continued safety,” said David Lucatch, CEO of KABN. “Together with this amazing group and a growing list of partners we will enable, through this and future verifiable identity and access credentials, people to interact with businesses, schools, entertainment venues, retailers, airlines, resorts, and others and do the things and go to the places that they did before the pandemic changed our lives.”

Healthcare issuers and individuals will be granted access to the system at no cost. Verifiers wishing to access the system will be charged a nominal subscription and micro-payment per verification, making it very cost efficient and effective to use the system for small and medium sized enterprises all the way up to major airlines, venues and facilities. The partners are committed to making the services affordable to all parties, so that everyone can get back to their everyday lives.

The KABN Network is working with leading industry partners to provide a safe and effective ecosystem that supports the issuance, ownership and verification of these verified identity and access credentials and is proud to be working with the following partners at the outset of this announcement covering a wide range of technologies, issuer, consumer, and verification engagement, with additional partners to be named as the program grows.

In addition to Liquid Avatar, our consortium partners Include:

Trust over IP Foundation (ToIP) – www.trustoverip.org

As a member of the Trust over IP Foundation (www.trustoverip.org) steering committee, The KABN Network is committed to the organization’s open-standard framework and tech stacks. ToIP recently released its Covid-19 Credentials Initiative (“CCI”) Governance Framework for public review.

Lumedic Exchange – www.lumedic.io

The KABN Network, as a founding partner, is working with the Lumedic Exchange (www.lumedic.io), an open-standards, decentralized framework for the healthcare industry giving patients greater control over their health data.

Loop Insights, Inc. – www.loopinsights.ai

Powering professional sports, entertainment, collegiate and other venues and facilities with Automatic Contract Tracing, Loop Insights, Inc. (www.loopinsights.ai) (TSXV:MTRX) has developed a fully managed contactless check-in platform that securely transfers contact information and triggers real-time notifications at scale.

The Campus Agency – www.thecampusagency.com

With reach to over 2,000 US College and University campuses and over 1.5 Million Gen Z students, alumni and families, The Campus Agency (www.thecampusagency.com) has been supporting innovative direct to student and online marketing programs for over 40 years.

TripXpertz – www.tripxpertz.com

Powering over 1,000 travel and government tourism boards, airlines, travel wholesalers and resorts in US, Canada, Mexico, the Caribbean and around the world, to more effectively reach their intended travel audiences with end to end travel marketing management, booking and analytics solutions TripXpertz (www.tripxpertz.com) is changing the way the travel industry reaches travelers and how travelers can receive better value from their travel experiences.

XTMwww.xtminc.com

As a fintech innovator in the challenger banking space, XTM (CSE:PAID) is a global card issuer and payment specialist that supports business and workers to expedite cashless earnings payout and reduce or eliminate banking fees. XTM powers a wide range of industry sectors, including the hospitality and personal care industries.

For more information on the program and / or how to become a consortium partner or participant, please visit www.liquidavatar.com

If you would like to join our mailing list and receive updates on KABN Systems NA Holdings Corp., please click here

About XTM Inc. – www.xtminc.com

XTM, www.xtminc.com is a Toronto-based fintech innovator in the challenger banking space helping business and workers alike expedite earnings payout and reduce or eliminate banking fees. We are a global card issuer and payment specialist providing free technology to business to automate and expedite worker payouts that can eliminate cash. XTM integrates businesses to a payment ecosystem that is coupled with a free mobile app and Mastercard debit card with free banking features. XTM drives enterprise value and creates a positive user experience.

XTM Inc. is publicly listed on the Canadian Securities Exchange (CSE) under the symbol “PAID” (CSE:PAID).

For further information please visit xtminc.com or contact:

[email protected]
416-260-1641

About KABN North America – www.kabnnaholdco.com

KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of Self Sovereign identity, empowering users to control and benefit from the use of their online identity. The KABN proprietary technology suite includes 4 key products:

Liquid Avatar is a verified Self Sovereign Identity platform that empowers users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allow users to manage and control their digital identity and Verifiable Access and Identity Credentials, and to use Liquid Avatars to share public and permission based private data when they want and with whom they want. www.liquidavatar.com

KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.

KABN Systems NA Holdings Corp. is publicly listed on the Canadian Securities Exchange (CSE) under the symbol “KABN” (CSE:KABN).

The Company also trades in the US under the symbol “TRWRF” and in Frankfurt under the symbol “4T51”

If you have not already joined our mailing list and would like to receive updates on KABN Systems NA Holdings Corp., please click here to join!

For more information, please visit www.kabnnaholdco.com or www.kabnsystemsna.com

For further information, please contact:

David Lucatch
Chief Executive Officer
647-725-7742 Ext. 701
mailto:[email protected]

US and Canadian Media Contact:

Nicole Rodrigues
NRPR Group
[email protected]

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the ability of the Company to generate revenues, roll out new programs and to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

SOURCE: KABN Systems NA Holdings Corp.

Kontrol Energy $KNR $KNR.ca $KNR.c $KNRLF Enters into Distribution Agreement with Grande West to Offer BioCloud Technology Covid-19 Detection Systems for Vicinity Buses $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 7:26 AM on Tuesday, December 15th, 2020
kontrol-logo
  • Entered into a distribution agreement with Grande West, a Canadian manufacturer of mid-sized multi-purpose transit vehicles for sale in Canada and the United States, to offer BioCloudTM technology to the Vicinity line of buses.
  • Under the terms of the non-exclusive distribution agreement, Grande West will offer the BioCloud solution as an option in its Vicinity LightningTM, Vicinity LT and Vicinity heavy duty bus specifications.
  • Grande West’s existing customers will be notified of the option to retrofit the BioCloud devices into existing fleets across Canada.

TORONTO, ON / December 15, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“) is pleased to announce that it has entered into a distribution agreement with Grande West, a Canadian manufacturer of mid-sized multi-purpose transit vehicles for sale in Canada and the United States, to offer BioCloudTM technology to the Vicinity line of buses.

“We are pleased to enter into this agreement with Grande West as we continue to target the important sector of ground transportation with an established and successful bus OEM. We are excited to be working with another disruptive Canadian company, focusing on a transit solution that will make buses safer and reduce risk of potential viral spread for the riders,” stated Paul Ghezzi, CEO Kontrol Energy. “We anticipate that this additional partnership will add another channel for incremental sales as the need for safe detection of airborne viruses in public spaces grows.”

Under the terms of the non-exclusive distribution agreement, Grande West will offer the BioCloud solution as an option in its Vicinity LightningTM, Vicinity LT and Vicinity heavy duty bus specifications. Grande West’s existing customers will be notified of the option to retrofit the BioCloud devices into existing fleets across Canada. United States customers will be serviced by working with Kontrol Energy’s exclusive distributor, United Safety and Survivability Corporation. Pricing will not be disclosed for industry competitive purposes.

William Trainer, President & CEO of Grande West stated, “Grande West is proud to be partnering with Kontrol in working towards making our Vicinity buses safer for all of our end users. The Company is expanding its product lines into Electric Vehicles and lighter duty models and ramping up its U.S. sales and expects significant growth in the coming years. We will do everything we can to offer the safest and most effective transit solutions to our customers.”

As an initial step, Grande West is immediately ordering two of BioCloud units for its offices and operations headquarters in Aldergrove to improve the safety considerations of its employees.

About BioCloudTM

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.

Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com

BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

About Kontrol Energy

Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at: www.sedar.com

About Grande West Transportation Group

Grande West Transportation is a Canadian company that designs and engineers mid-size multi-purpose transit vehicles for public and commercial enterprises. Grande West utilizes world-class manufacturing partners to produce the Purpose-Built VicinityTM medium and heavy-duty buses available in electric, CNG, gas and clean diesel drive systems. The Vicinity LightningTM EV with an electric propulsion drive system is available for 2021 deliveries.

The Company has been successful in supplying Canadian municipal transportation agencies and private operators with new buses. Grande West is compliant to Buy America certification, and with a strong distribution chain in the U.S., is actively pursuing opportunities in public and private transit fleet operations that would benefit from Grande West’s vehicles.

www.grandewest.com

www.vicinitybus.com

For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloudTM (“BioCloud”) are subject to the risk that the Kontrol BioCloud may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE: Kontrol Energy Corp.

VIDEO – Mountain Valley MD $MVMD.ca Catches Small Cap Fire After #Ivermectin Testimony In US Senate Called “Miraculous Effectiveness” In Prohibiting Transmission Of #COVID-19

Posted by AGORACOM-JC at 4:19 PM on Monday, December 14th, 2020

“It basically obliterates transmission of this virus”  

This was the testimony of  Pierre Kory, M.D., Associate Professor of Medicine at St. Luke’s Aurora Medical Center, delivers passionate testimony during the Senate Homeland Security and Governmental Affairs Committee hearing on “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution, Part II.”

We interviewed Leigh Hughes, newly appointed Advisor to MVMD who will be supporting the Company in the areas of M&A, corporate finance and pharmaceutical licensing, to provide us with further insight as to why the testimony of Dr. Kory is so relevant to MVMD … and why Dr. Kory actually called MVMD last week to discuss the Company’s involvement with Ivermectin.

Mountain Valley MD has traded over 50,000,000 shares in the last 3 trading days, so there is a clear need for information amongst retail investors.